A new nitrate derivative of piperazine: its influence on platelet activity
Authors:
- 1 March 2007
- journal article
- research article
- Published by Wolters Kluwer Health in Blood Coagulation & Fibrinolysis
- Vol. 18 (2) , 151-156
Abstract
Nitric oxide (NO) is a potent vasodilator and inhibitor of platelet activation. Its donors, organic nitrates, are still a main group of drugs administered in ischaemic heart disease. The aim of this study was to investigate the effect of a new NO-donor analogue, 1-(3-piperidinepropionyl)-4-(2-nitrooxy-3-piperidinepropyl) piperazine trihydrochloride (NO-P), on platelet activity. Its influence on the main mechanisms of human platelet activation (adhesion, shape change, secretion and aggregation) was evaluated with the use of a pharmacological model produced on the basis of known platelet activation measuring methods and our computer program. Our experiments revealed that the new NO derivative of piperazine favourably influences platelet activity, and decreases adhesion (spontaneous and induced by ADP) and aggregation. NO-P shows the same direction of action as nitroglycerin (used as a model compound), and is even stronger in the case of ADP-induced and collagen-induced aggregation. These findings broaden the possibility of using NO-P in cardiovascular diseases. Furthermore, our computer program, used to evaluate kinetic parameters of platelet aggregation, shape change, and the adhesion measuring method, provides a simple and accessible experimental model. This model can be useful in in-vitro screening studies, estimating the influence of new compounds (potential drugs) on platelet activity.Keywords
This publication has 20 references indexed in Scilit:
- Inhibition of platelet aggregation by nitric oxide donors improves with restPlatelets, 2003
- Nitric Oxide–Releasing DrugsAnnual Review of Pharmacology and Toxicology, 2003
- Nitric Oxide Donors and Cardiovascular Agents Modulating the Bioactivity of Nitric OxideCirculation Research, 2002
- Platelet activation: assessment and quantificationEuropean Heart Journal, 2001
- Nitric Oxide DonorsProceedings of the Society for Experimental Biology and Medicine, 2000
- Inhalation of nitric oxide inhibits ADP-induced platelet aggregation and alpha-granule releasePlatelets, 1999
- Epinephrine induces a late thromboxane-dependent platelet shape change and enhances synergistically the shape change induced by other platelet agonistsPlatelets, 1996
- Rapid photometric method for estimation of platelet count in blood plasma or platelet suspensionThrombosis Research, 1989
- Saliva secretion of chloroquine in manJournal of Pharmacy and Pharmacology, 1986
- Platelet activation detected by turbidometric shape-change analysis. Differential influence of cytochalasin B and prostaglandin E1Thrombosis Research, 1978